curasan AG (Germany) Profile

EUR 0.01  0.95%

curasan AG Summary

curasan AG (CUR) is traded on Frankfurt Stock Exchange in Germany. It is located in Lindigstrasse 4 and employs 36 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 16.5 M. curasan AG classifies itself under Healthcare sector and is part of Healthcare Products industry. This company has 11.42 M outstanding shares. CURASAN has accumulated about 587 K in cash with (1.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05.
Check curasan AG Probability Of Bankruptcy

curasan AG Risk Profiles

Key Fundamentals

curasan AG Against Markets

Current Ratings

curasan AG 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 25% 
Equity ratings for curasan AG are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
curasan AG develops, produces, and markets biomaterials and medical devices for bone and tissue regeneration worldwide. The company was founded in 1988 and is based in Kleinostheim, Germany. curasan AG operates under Healthcare Products classification in Germany and traded on Frankfurt Stock Exchange. It employs 36 people. more
Namecurasan AG
CEORichard GarrView All
Macroaxis Advice
Healthcare, Healthcare Products
InstrumentGermany Stock View All
Business AddressLindigstrasse 4
Foreign Associate  USA
ExchangeFrankfurt Stock Exchange
IndustryHealthcare Products
Contact Number49 6027 40 900 51
CurrencyEUR - Euro

Diversify with curasan AG

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add curasan AG to your portfolio


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


curasan AG Corporate Directors
William Oldaker Independent Director
Stanley Westreich Independent Director
Scott Ogilvie Independent Director